>_ QFI Terminal
TerminalStocks › GLAS

Glass House Brands Inc (GLAS) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · US
$7.93 -0.75%
Last updated Sep 20, 2026 14:56 UTC

GLAS Key Statistics

Market Cap$613.99M
P/E (TTM)-12.20
P/S (TTM)3.76
P/B (TTM)3.83
Revenue (TTM)$163.17M
EPS (TTM)$-0.65
Dividend Yield
ROE (TTM)-50.85%
Net Margin-31.00%
Gross Margin33.06%
52W High$13.25
52W Low$7.70
Analyst View
Price Target$16.00
Employees392
Volume648,283

About Glass House Brands Inc

Glass House Brands, Inc. operates as an integrated cannabis company in the United States with focus on the California market and building brands to serve consumers across various segments. The company is involved in greenhouse cultivation operations, manufacturing practices, brand-building, and retailing activities. The company offers its cannabis products through its portfolio of brands, which includes Glass House Farms, PLUS Products, Allswell, Forbidden Flowers, and Mama Sue Wellness. The company was founded by Kyle Kazan, Graham Farrar and Jocelyn Rosenwald in 2015 and is headquartered in Long Beach, CA.

CEO: Kyle Kazan. Company website

GLAS — Frequently Asked Questions

What is the GLAS stock price today?

Glass House Brands Inc (GLAS) trades at $7.93, down 0.75% on the day, as of Sep 20, 2026 14:56 UTC.

What is Glass House Brands Inc's market cap?

Glass House Brands Inc has a market capitalisation of $613.99M, calculated from the live GLAS share price and shares outstanding.

What is the P/E ratio of GLAS?

GLAS has no meaningful price-to-earnings ratio: Glass House Brands Inc lost $0.65 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does Glass House Brands Inc make?

Glass House Brands Inc generated revenue of $163.17M over the trailing twelve months, which puts the stock at 3.76 times sales.

What is the 52-week range for GLAS?

GLAS has traded between $7.70 and $13.25 over the past 52 weeks, and the last price is 40.2% below that high.

Is Glass House Brands Inc profitable?

No. Glass House Brands Inc is loss-making, with a net margin of -31.00% over the trailing twelve months.

What is the analyst price target for GLAS?

Wall Street analysts rate GLAS without a published consensus, with an average price target of $16.00, 101.8% above the current price.

What sector is Glass House Brands Inc in?

Glass House Brands Inc is classified under the Healthcare sector and the Drug Manufacturers - Specialty & Generic industry, and is domiciled in US.

Who is the CEO of Glass House Brands Inc?

Kyle Kazan is the chief executive of Glass House Brands Inc, which employs 392 people.

Where can I track GLAS in real time?

QFI Terminal shows GLAS with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See GLAS live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open GLAS in Terminal See plans

Drug Manufacturers - Specialty & Generic stocks

TEVA Teva Pharmaceutical Industries Limited VTRS Viatris Inc. HLN Haleon plc ZTS Zoetis Inc. ELAN Elanco Animal Health Incorporated PRGO Perrigo Company plc LNTH Lantheus Holdings, Inc. PAHC Phibro Animal Health Corporation

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.